Displaying 121 - 130 of 330
Artificial Intelligence and the Future of Blood Cancers webcast
Updated:
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
Research
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma
Problems sleeping during and after treatment
Updated:
Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
Treatment and side effects
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
Updated:
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Myeloproliferative neoplasms
Understanding essential thrombocythemia (ET): Diagnosis, treatments and follow-up care: MPN conference 2025
Updated:
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many…
Myeloproliferative neoplasms
Diffuse Large B-Cell Lymphoma (DLBCL)
Updated:
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). DLBCL is fast-growing (aggressive) but treatable. It most often appears in older adults but can appear at any age.
Lymphoma
Cutaneous T-cell Lymphoma (CTCL)
Updated:
Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.
Lymphoma
Understanding mantle cell lymphoma (MCL)
Updated:
Mantle cell lymphoma (MCL) is an aggressive subtype of non-Hodgkin lymphoma. It is a blood cancer of the B-lymphocytes (type of white blood cell that fights infections) found in the bone marrow. Learn more about MCL in this animated video.
Lymphoma